Literature DB >> 9620387

Detection of antigen in sera of patients with invasive aspergillosis: intra- and interlaboratory reproducibility. The Dutch Interuniversity Working Party for Invasive Mycoses.

P E Verweij1, Z Erjavec, W Sluiters, W Goessens, M Rozenberg-Arska, Y J Debets-Ossenkopp, H F Guiot, J F Meis.   

Abstract

The intra- and interlaboratory reproducibilities of a commercial sandwich enzyme-linked immunosorbent assay (ELISA) for the detection of Aspergillus galactomannan in serum (Platelia Aspergillus; Sanofi Diagnostics Pasteur, Marnes-La-Coquette, France) were evaluated in six laboratories of university hospitals. Twenty serum samples were obtained from 12 neutropenic patients including 6 with invasive aspergillosis. These samples were blinded and sent to each center together with eight blinded ELISA-negative serum samples spiked with known concentrations of galactomannan. The centers were provided with ELISA microtiter plates from a single batch and a detailed protocol. Ten clinical samples showed ELISA reactivity, while 10 samples were ELISA negative. The mean coefficient of variation (CV) of the optical density values was 4.24% within a single assay and 25.6% between runs. The interassay CV of the ratios for the serum samples tested was 18.6%. Analysis of ordinal interpretation of the ELISA result (i.e., negative, gray zone, or positive) showed excellent reproducibility. Recalculation of the cutoff values for positive and negative samples suggested that the cutoff level recommended by the manufacturer could be lowered from 1.0 to 0.8 for negative samples and from 1.5 to 1.0 for positive samples. The intra- and interlaboratory reproducibilities were excellent when the ELISA results were interpreted as ordinal data, but considerable variation in optical density values and, to a lesser extent, in the ratios for the serum samples tested, was observed between runs. High assay variability was also found for serum samples spiked with known concentrations of galactomannan. Therefore, antigen titers in serum samples from a single patient, measured in different runs, should be compared with caution.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620387      PMCID: PMC104887     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1968-10       Impact factor: 17.737

2.  Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis.

Authors:  P E Verweij; A J Rijs; B E De Pauw; A M Horrevorts; J A Hoogkamp-Korstanje; J F Meis
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

3.  A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis.

Authors:  D Stynen; A Goris; J Sarfati; J P Latgé
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

4.  New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test.

Authors:  R Kappe; A Schulze-Berge
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

5.  Specific amplification of Aspergillus fumigatus DNA by polymerase chain reaction.

Authors:  L V Reddy; A Kumar; V P Kurup
Journal:  Mol Cell Probes       Date:  1993-04       Impact factor: 2.365

6.  The detection of Aspergillus spp. by the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid.

Authors:  C M Tang; D W Holden; A Aufauvre-Brown; J Cohen
Journal:  Am Rev Respir Dis       Date:  1993-11

7.  The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen.

Authors:  J R Sabetta; P Miniter; V T Andriole
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

8.  Rat monoclonal antibodies against Aspergillus galactomannan.

Authors:  D Stynen; J Sarfati; A Goris; M C Prévost; M Lesourd; H Kamphuis; V Darras; J P Latgé
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

9.  General primer-mediated PCR for detection of Aspergillus species.

Authors:  W J Melchers; P E Verweij; P van den Hurk; A van Belkum; B E De Pauw; J A Hoogkamp-Korstanje; J F Meis
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

10.  Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis.

Authors:  V Hopwood; E M Johnson; J M Cornish; A B Foot; E G Evans; D W Warnock
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

View more
  14 in total

1.  Recent Advances in the Management of Infections in Liver Transplant Recipients.

Authors:  Nina Singh
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

2.  Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis.

Authors:  Claudine Pinel; Hélène Fricker-Hidalgo; Bernadette Lebeau; Frédéric Garban; Rébecca Hamidfar; Pierre Ambroise-Thomas; Renée Grillot
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

3.  Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments.

Authors:  Emmanuelle Bart-Delabesse; Maria Basile; Ahmad Al Jijakli; Didier Souville; Frédérick Gay; Bruno Philippe; Philippe Bossi; Martin Danis; Jean-Paul Vernant; Annick Datry
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Reproducibility of low galactomannan enzyme immunoassay index values tested in multiple laboratories.

Authors:  Arlo Upton; Anja Gugel; Wendy Leisenring; Ajit Limaye; Barbara Alexander; Randall Hayden; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 5.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

6.  Follow-up of anti-Aspergillus IgG and IgA antibodies in bone marrow transplanted patients with invasive aspergillosis.

Authors:  S Centeno-Lima; J M de Lacerda; J A do Carmo; M Abecasis; C Casimiro; F Exposto
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

7.  Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis.

Authors:  Cathal E O'Sullivan; Miki Kasai; Andrea Francesconi; Vidmantas Petraitis; Ruta Petraitiene; Amy M Kelaher; Alia A Sarafandi; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction.

Authors:  Thomas J Walsh; Shmuel Shoham; Ruta Petraitiene; Tin Sein; Robert Schaufele; Amy Kelaher; Heidi Murray; Christine Mya-San; John Bacher; Vidmantas Petraitis
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Diagnosis of IPA in HIV: the role of the chest X-ray and radiologist.

Authors:  Uta Zaspel; David W Denning; Arne J Lemke; Reginald Greene; Dirk Schürmann; Georg Maschmeyer; Markus Ruhnke; Raoul Herbrecht; Patricia Ribaud; Olivier Lortholary; Harmien Zonderland; Klaus F Rabe; Rainer Röttgen; Roland Bittner; Klaus Neumann; Joerg W Oestmann
Journal:  Eur Radiol       Date:  2004-08-11       Impact factor: 5.315

10.  Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum.

Authors:  Nina Singh; Asia Obman; Shahid Husain; Sherrie Aspinall; Sue Mietzner; Janet E Stout
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.